Cargando…
Management of rheumatic complications of ICI therapy: a rheumatology viewpoint
Since immune checkpoint inhibitors became the standard of care for an increasing number of indications, more patients have been exposed to these drugs and physicians are more challenged with the management of a unique spectrum of immune-related adverse events (irAEs) associated with immune checkpoin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900914/ https://www.ncbi.nlm.nih.gov/pubmed/31816078 http://dx.doi.org/10.1093/rheumatology/kez360 |